Covalent modification of cytoskeletal proteins in neuronal cells by tryptamine-4,5-dione

Redox Biology

Volumn 2, Issue 1, 2014, Pages 983-990

  Kato, Yoji ^a   Ono, Shigeki ^a   Kitamoto, Noritoshi ^a   Kettle, Anthony J ^b  

^a UNIVERSITY OF HYOGO   (Japan)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

5 Hydroxytryptamine; Adduct; Antibody; Neuronal cells; Quinone; Tryptamine 4,5 dione

Indexed keywords

ALPHA TUBULIN; BETA ACTIN; BETA TUBULIN; CHLORIDE ION; CYTOSKELETON PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MONOCLONAL ANTIBODY; MYELOPEROXIDASE; NEUROFILAMENT L PROTEIN; TRYPTAMINE 4,5 DIONE; UNCLASSIFIED DRUG; VIMENTIN; 5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; ANTIGEN; BOVINE SERUM ALBUMIN; DITHIOTHREITOL; EPITOPE; FREUND ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; MELATONIN; NEUROFILAMENT PROTEIN; QUINONE DERIVATIVE; SEROTONIN; INDOLE DERIVATIVE; NERVE PROTEIN; TRYPTAMINE DERIVATIVE; TRYPTAMINE-4,5-DIONE;

ARTICLE; CONTROLLED STUDY; COVALENT BOND; ENZYME MECHANISM; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; NERVE CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN MODIFICATION; PROTEIN POLYMERIZATION; PROTEIN TARGETING; SEROTONIN METABOLISM; SUICIDE SUBSTRATE; WESTERN BLOTTING; ANIMAL EXPERIMENT; ANTIGENICITY; CYTOSOL; DNA ADDUCT; ENZYME SUBSTRATE; HUMAN; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN FUNCTION; CHEMISTRY; DRUG EFFECTS; METABOLISM; PROTEIN PROCESSING; TUMOR CELL LINE;

CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; HUMANS; INDOLEQUINONES; NERVE TISSUE PROTEINS; NEURONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRYPTAMINES;

EID: 84908692285     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.08.004     Document Type: Article

References (25)

1. Wrona M.Z., Dryhurst G. Oxidation of serotonin by superoxide radical: implications to neurodegenerative brain disorders. Chemical Research in Toxicology 1998, 11:639-650. http://www.ncbi.nlm.nih.gov/pubmed/9625732, 10.1021/tx970185w.
2. Ximenes V.F., Maghzal G.J., Turner R., Kato Y., Winterbourn C.C., Kettle A.J. Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. Biochemical Journal 2010, 425:285-293. http://www.ncbi.nlm.nih.gov/pubmed/19828014, 10.1042/BJ20090776.
3. Jones C.E., Underwood C.K., Coulson E.J., Taylor P.J. Copper induced oxidation of serotonin: analysis of products and toxicity. Journal of Neurochemistry 2007, 102:1035-1043. http://www.ncbi.nlm.nih.gov/pubmed/17663749, 10.1111/j.1471-4159.2007.04602.x.
4. Huether G., Fettkötter I., Keilhoff G., Wolf G. Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of activated microglia. Journal of Neurochemistry 1997, 69:2096-2101. http://www.ncbi.nlm.nih.gov/pubmed/9349555.
5. Jiang X.R., Wrona M.Z., Alguindigue S.S., Dryhurst G. Reactions of the putative neurotoxin tryptamine-4,5-dione with l-cysteine and other thiols. Chemical Research in Toxicology 2004, 17:357-369. http://www.ncbi.nlm.nih.gov/pubmed/15025506, 10.1021/tx020084k.
6. Wrona M.Z., Singh S., Dryhurst G. Influence of l-cysteine on the oxidation chemistry of serotonin. Bioorganic Chemistry 1994, 22:421-445. 10.1006/bioo.1994.1035.
7. Jiang X.R., Dryhurst G. Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes by a putative aberrant metabolite of serotonin, tryptamine-4,5-dione. Chemical Research in Toxicology 2002, 15:1242-1247. http://www.ncbi.nlm.nih.gov/pubmed/12387620, 10.1021/tx020029b.
8. Wrona M.Z., Dryhurst G. A putative metabolite of serotonin, tryptamine-4,5-dione, is an irreversible inhibitor of tryptophan hydroxylase: possible relevance to the serotonergic neurotoxicity of methamphetamine. Chemical Research in Toxicology 2001, 14:1184-1192. http://www.ncbi.nlm.nih.gov/pubmed/11559032, 10.1021/tx010037c.
9. Jasin H.E. Generation of IgG aggregates by the myeloperoxidase-hydrogen peroxide system. Journal of Immunology (Baltimore, Md.: 1950) 1983, 130:1918-1923. http://www.ncbi.nlm.nih.gov/pubmed/6300234.
10. Salman-Tabcheh S., Guérin M.C., Torreilles J. Potential role of the peroxidase-dependent metabolism of serotonin in lowering the polymorphonuclear leukocyte bactericidal function. Free Radical Research 1996, 24:61-68. http://www.ncbi.nlm.nih.gov/pubmed/8747893, 10.3109/10715769609088000.
11. Hallingbäck H.R., Gabdoulline R.R., Wade R.C. Comparison of the binding and reactivity of plant and mammalian peroxidases to indole derivatives by computational docking. Biochemistry 2006, 45:2940-2950. http://www.ncbi.nlm.nih.gov/pubmed/16503648, 10.1021/bi051510e.
12. Reynolds W.F., Rhees J., Maciejewski D., Paladino T., Sieburg H., Maki R.A., Masliah E. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Experimental Neurology 1999, 155:31-41. http://www.ncbi.nlm.nih.gov/pubmed/9918702, 10.1006/exnr.1998.6977.
13. Kato Y., Peskin A.V., Dickerhof N., Harwood D.T., Kettle A.J. Myeloperoxidase catalyzes the conjugation of serotonin to thiols via free radicals and tryptamine-4,5-dione. Chemical Research in Toxicology 2012, 25:2322-2332. http://www.ncbi.nlm.nih.gov/pubmed/23009681, 10.1021/tx300218f.
14. Singh S., Wrona M.Z., Dryhurst G. Synthesis and reactivity of the putative neurotoxin tryptamine-4,5-dione. Bioorganic Chemistry 1992, 20:189-203. 10.1016/0045-2068(92)90012-R.
15. Zheng J., Hammock B.D. Development of polyclonal antibodies for detection of protein modification by 1,2-naphthoquinone. Chemical Research in Toxicology 1996, 9:904-909. http://www.ncbi.nlm.nih.gov/pubmed/8828928, 10.1021/tx960014b.
16. Kato Y., Kawai Y., Morinaga H., Kondo H., Dozaki N., Kitamoto N., Osawa T. Immunogenicity of a brominated protein and successive establishment of a monoclonal antibody to dihalogenated tyrosine. Free Radical Biology and Medicine 2005, 38:24-31. http://www.ncbi.nlm.nih.gov/pubmed/15589368, 10.1016/j.freeradbiomed.2004.09.013.
17. Paz M.A., Flückiger R., Boak A., Kagan H.M., Gallop P.M. Specific detection of quinoproteins by redox-cycling staining. Journal of Biological Chemistry 1991, 266:689-692. http://www.ncbi.nlm.nih.gov/pubmed/1702437.
18. Ximenes V.F., Silva S.O., Rodrigues M.R., Catalani L.H., Maghzal G.J., Kettle A.J., Campa A. Superoxide-dependent oxidation of melatonin by myeloperoxidase. Journal of Biological Chemistry 2005, 280:38160-38169. http://www.ncbi.nlm.nih.gov/pubmed/16148002, 10.1074/jbc.M506384200.
19. Pamplona R., Dalfó E., Ayala V., Bellmunt M.J., Prat J., Ferrer I., Portero-Otín M. Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets. Journal of Biological Chemistry 2005, 280:21522-21530. http://www.ncbi.nlm.nih.gov/pubmed/15799962, 10.1074/jbc.M502255200.
20. Jeong M.S., Kang J.H. Acrolein, the toxic endogenous aldehyde, induces neurofilament-L aggregation. BMB Reports 2008, 41:635-639. http://www.ncbi.nlm.nih.gov/pubmed/18823586, 10.5483/BMBRep.2008.41.9.635.
21. Van Laar V.S., Mishizen A.J., Cascio M., Hastings T.G. Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiology of Disease 2009, 34:487-500. http://www.ncbi.nlm.nih.gov/pubmed/19332121, 10.1016/j.nbd.2009.03.004.
22. Mi L., Hood B.L., Stewart N.A., Xiao Z., Govind S., Wang X., Conrads T.P., Veenstra T.D., Chung F.L. Identification of potential protein targets of isothiocyanates by proteomics. Chemical Research in Toxicology 2011, 24:1735-1743. http://www.ncbi.nlm.nih.gov/pubmed/21838287, 10.1021/tx2002806.
23. Liu L., Marcocci L., Wong C.M., Park A.M., Suzuki Y.J. Serotonin-mediated protein carbonylation in the right heart. Free Radical Biology and Medicine 2008, 45:847-854. http://www.ncbi.nlm.nih.gov/pubmed/18616998, 10.1016/j.freeradbiomed.2008.06.008.
24. Ban Y., Watanabe T., Miyazaki A., Nakano Y., Tobe T., Idei T., Iguchi T., Ban Y., Katagiri T. Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia. Atherosclerosis 2007, 195:153-159. http://www.ncbi.nlm.nih.gov/pubmed/17049533, 10.1016/j.atherosclerosis.2006.09.005.
25. Maximino C., Araujo J., Leão L.K., Grisolia A.B., Oliveira K.R., Lima M.G., Batista Ede J., Crespo-López M.E., Gouveia A., Herculano A.M. Possible role of serotoninergic system in the neurobehavioral impairment induced by acute methylmercury exposure in zebrafish (Danio rerio). Neurotoxicology and Teratology 2011, 33:727-734. 10.1016/j.ntt.2011.08.006.